Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

17%

2 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(60.0%)
Phase 3
2(20.0%)
Phase 2
2(20.0%)
10Total
N/A(6)
Phase 3(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT07210333Not Yet Recruiting

Non-invasive Intracranial Pressure Monitoring to Improve Emergency Care in Brazil's Public Health System

Role: collaborator

NCT06191510Completed

Xenogenic Bone Intentionally Left Exposed

Role: collaborator

NCT03933176Not ApplicableWithdrawn

Absence of Liner Following the Selective Caries Removal (ALFSCaRe)

Role: lead

NCT03523598Not ApplicableCompleted

Potassium Nitrate and Post-bleaching Sensitivity

Role: lead

NCT02941653Not ApplicableCompleted

Potassium Oxalate and Potassium Nitrate and Post-bleaching Sensitivity

Role: lead

NCT03153657Phase 3Completed

Piroxicam-beta-Cyclodextrin on Tooth Sensitivity Caused by In-office Bleaching

Role: lead

NCT02494193Not ApplicableCompleted

Indirect Pulp Capping With Resin Modified Glass Ionomer

Role: lead

NCT02935114Phase 3Completed

IN-OFFICE TOOTH BLEACHING WITH 37% CARBAMIDE PEROXIDE

Role: lead

NCT02065843Phase 2Completed

Three Anxiolytic Drugs Used in Third Molar Surgery

Role: lead

NCT02463552Not ApplicableCompleted

Naproxen on Tooth Sensitivity Caused by In-office Bleaching

Role: lead

NCT02067715Not ApplicableCompleted

Effectiveness of Sealed In-office Bleaching Technique: Randomized Controlled Clinical Trial

Role: lead

NCT02033512Phase 2Completed

TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS

Role: collaborator

All 12 trials loaded